Lifecore Biomedical Net Income

Lifecore Biomedical (LFCR) currently reports a net income of $-27M as of December 2026. That compares with $-32M in the prior-year period — up 17.0% year over year. That is below the Materials sector average of $19B. Use the charts on this page to explore Lifecore Biomedical's net income history and peer comparisons.

Lifecore Biomedical's net income increased from $-32M to $-27M — a 17.0% year-over-year increase (period ending December 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lifecore Biomedical's net income of $-27M is lower than the Materials sector average of $19B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Lifecore Biomedical reported $-27M in net income as of December 2026. That compares with $-32M in the prior-year period — up 17.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-27M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is $19B. From there, open related valuation or income-statement pages for Lifecore Biomedical, and consider following LFCR for alerts when major investors trade the stock.